Form EFFECT Cogent Biosciences, Inc.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 9, 2025 |
| Accession Number: | 0001193125-25-113367 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jiangxi China-Africa Gen-Z Youth Entrepreneurship Competition Concludes Successfully
- MEGAN FOX BECOMES CO-OWNER OF SUBS.COM AND LAUNCHES OFFICIAL PAGE
- Cryptocurrency News: Coinbase Folds $2.9 Billion Deribit Into One Exchange, With a Fact Check on the Pepeto Presale
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share